Scientists test new prostate disease drug
User rating: 4.8 / 5 after 4 vote(s)
A Canadian-headquartered biopharmaceutical company is conducting the second Phase 3 study of a new drug designed to treat prostate disease.
Full story »
A Canadian-headquartered biopharmaceutical company is conducting the second Phase 3 study of a new drug designed to treat prostate disease.